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W. Weitschies‡aa and A. Brodkorb‡*ab
Simulated gastro-intestinal digestion is widely employed in many fields of food and nutritional sciences, as
conducting human trials are often costly, resource intensive, and ethically disputable. As a consequence, in
vitro alternatives that determine endpoints such as the bioaccessibility of nutrients and non-nutrients or the
digestibility of macronutrients (e.g. lipids, proteins and carbohydrates) are used for screening and building
new hypotheses. Various digestion models have been proposed, often impeding the possibility to compare
results across research teams. For example, a large variety of enzymes from different sources such as of
porcine, rabbit or human origin have been used, differing in their activity and characterization. Differences in
pH, mineral type, ionic strength and digestion time, which alter enzyme activity and other phenomena, may
also considerably alter results. Other parameters such as the presence of phospholipids, individual enzymes
such as gastric lipase and digestive emulsifiers vs. their mixtures (e.g. pancreatin and bile salts), and the ratio
of food bolus to digestive fluids, have also been discussed at length. In the present consensus paper, within
the COST Infogest network, we propose a general standardised and practical static digestion method based
on physiologically relevant conditions that can be applied for various endpoints, which may be amended to
accommodate further specific requirements. A frameset of parameters including the oral, gastric and small
intestinal digestion are outlined and their relevance discussed in relation to available in vivo data and
enzymes. This consensus paper will give a detailed protocol and a line-by-line, guidance, recommendations
and justifications but also limitation of the proposed model. This harmonised static, in vitro digestion method
for food should aid the production of more comparable data in the future.erlands. E-mail: Mans.Minekus@tno.nl
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View Article OnlineIntroduction
In vitromethods simulating digestion processes are widely used
to study the gastro-intestinal behaviour of food or pharmaceu-
ticals. Although human nutritional studies are still being
considered the “gold standard” for addressing diet related
questions, in vitro methods have the advantage of being more
rapid, less expensive, less labour intensive, and do not have
ethical restrictions. This allows a relatively large number of
samples to be measured in parallel for screening purposes.
Reproducibility, choice of controlled conditions and easy
sampling at the site of interest make in vitro models very suit-
able for mechanistic studies and hypothesis building.
Simulated digestion methods typically include the oral,
gastric and small intestinal phases, and occasionally large
intestinal fermentation. These methods try to mimic physio-
logical conditions in vivo, taking into account the presence of
digestive enzymes and their concentrations, pH, digestion time,
and salt concentrations, among other factors. Some computer-
ized sophisticated models such as the Dutch TNO gastrointes-
tinal tract model,1 the model by the English Institute of Food
Research2 or by the French INRA3 allowing the simulation of
dynamic aspects of digestion, such as transport of digested
meals, variable enzyme concentrations and pH changes over
time. However, the majority of models reported in literature are
static ones,4 i.e.models with constant ratios of meal to enzymes,
salt, bile acids etc. at each step of digestion.
Static models of human digestion have been used to address
such diverse scientic questions as the digestibility and bio-
accessibility (i.e. the amount of a compound that is released
from the matrix and is considered to be available for absorption
through the gut wall) of pharmaceuticals,5 mycotoxins,6 and
macronutrients such as proteins,7,8 carbohydrates9 and
lipids.10,11 They have also been used to study matrix release of
micronutrients such as minerals and trace elements,12 and
secondary plant compounds including carotenoids13 and poly-
phenols.14,15 Some digestion methods are used to produce bio-
accessible fractions that can be used to address further
mechanistic questions, such as intestinal transport by
employing Caco-2 cells.16 Although many in vitro methods are
derived from earlier reported methods, there is signicant
variation in the use of in vitro digestion parameters between the
individual models described in literature,17–19 impeding the
possibility to compare results across research-groups and to
deduce general ndings. While altering some of theserInstitute of Food Research, Norwich, NR4 7UA Norfolk, UK. E-mail: Alan.Mackie@
ifr.ac.uk
sUR1268 Biopolyme`res Interactions Assemblages, INRA, F-44300, Nantes, France.
E-mail: Sebastien.Marze@nantes.inra.fr
tDepartment of Food Science, University of Massachusetts, Chenoweth Lab.,
Amherst, MA 01003, USA. E-mail: mcclements@foodsci.umass.edu
uInstituto de Investigacio´n en Ciencias de la Alimentacio´n (CIAL, CSIC-UAM),
Nicola´s Cabrera 9, 28049 Madrid, Spain. E-mail: i.recio@csic.es
vInstituto de Biologia Experimental e Tecnolo´gica, Apartado 12, 2781-901 Oeiras,
Portugal
wInstituto de Tecnologia Qu´ımica e Biolo´gica, Universidade Nova de Lisboa, Av. da
Repu´blica, EAN, 2781-901 Oeiras, Portugal. E-mail: csantos@ibet.pt
1114 | Food Funct., 2014, 5, 1113–1124parameters may have a limited impact on the matrix release or
digestibility of some compounds, there could be a large impact
for other ingredients. Enzyme activity is also altered by pH and
the concentration of salts such as calcium. The applied gastric
pH may vary greatly between the models, i.e. from pH 220 to pH
4.21 The COST action INFOGEST22 is an international network
joined by more than 200 scientists from 32 countries working in
the eld of digestion. One aim of the network is to consolidate
conditions for simulated digestion of food and nd a
consensus, if possible, for a digestion model. The group is
aware that no conditions outlined will be suited for all under-
lying research questions. However, the authors of this manu-
script strived to describe a “smallest common denominator”,
i.e. a set of conditions that are close to the physiological situa-
tion, are practical, and can be seen as a basic suggestion to
address various research questions. Further amendments of
these suggested conditions may be needed, for example to
simulate digestion in infants or the elderly, which may differ
considerably in enzyme concentration.23–25 For more accurate
simulation of in vivo conditions, dynamic models should be
used. In the next sections, we describe our recommendations
for a standardised digestion method which is based on the
current state of knowledge on in vivo digestion conditions, and
employs widely available instrumentation and chemicals.Experimental – in vitro digestion
protocol
This section describes a detailed line-by-line protocol, which is
also summarised in Fig. 1. Further information and justica-
tion on the choice and concentration of chemicals, inclusion or
omission of certain steps are discussed in greater detail in the
following section “In vitro digestion parameters – recommen-
dation and justication”.Materials
All materials are standard analytical grade. Sodium bicarbonate
(0.5 M) should be ltered through a 0.22 mm lter under
vacuum. It can be stored at 2–5 C for approximately onemonth.
The type of enzyme products, mostly provided by Sigma Aldrich
(St Louis, Mo), is only a recommendation and similar products
of comparable quality from other providers can be used.
Enzyme activities are based on commonly used assays. Detailed
protocols of the enzyme assays are outlined in the ESI.† a-xDepartment of Biological and Agricultural Engineering, Department of Food Science
and Technology, University of California, Davis, CA 95616, USA. E-mail: rpsingh@
ucdavis.edu
yDepartment of Chemistry, Biotechnology and Food Science, Norwegian University of
Life Sciences, 1432 Aas, Norway. E-mail: Gerd.Vegarud@umb.no
zLeatherhead Food Research, Randalls Road, Leatherhead, Surrey KT22 7RY, UK.
E-mail: MWickham@leatherheadfood.com
aaErnst Moritz Arndt University of Greifswald, D-17487 Greifswald, Germany.
E-mail: Werner.Weitschies@uni-greifswald.de
abTeagasc Food Research Centre, Moorepark, Fermoy, County Cork, Ireland. E-mail:
Andre.Brodkorb@teagasc.ie
This journal is © The Royal Society of Chemistry 2014
Fig. 1 Overview and flow diagram of a simulated in vitro digestion
method. SSF, SGF and SIF are Simulated Salivary Fluid, Simulated
Gastric Fluid and Simulated Intestinal Fluid, respectively. Enzyme
activities are in units per mL of final digestion mixture at each corre-
sponding digestion phase.
Table 1 Recommended concentrations of electrolytes in Simulated
Salivary Fluid (SSF), Simulated Gastric Fluid (SGF) and Simulated
Intestinal Fluid (SIF), based on human in vivo data
Constituent
SSF SGF SIF
mmol L1 Ref. mmol L1 Ref. mmol L1 Ref.
Paper Food & Function
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 0
7 
A
pr
il 
20
14
. D
ow
nl
oa
de
d 
on
 8
/2
6/
20
20
 1
1:
25
:0
8 
A
M
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article OnlineAmylase (EC 3.2.1.1) activity is based on soluble potato starch:
one unit liberates 1.0 mg of maltose from starch in 3 minutes at
pH 6.9 at 20 C. Porcine Pepsin (EC 3.4.23.1) activity is based on
bovine blood haemoglobin as a substrate: one unit will produce
a DA280 of 0.001 per minute at pH 2.0 and 37 C, measured as
TCA-soluble products. Porcine trypsin (EC 3.4.21.4) activity is
based on p-toluene-sulfonyl-L-arginine methyl ester (TAME):
one unit hydrolyses 1 mmol of TAME per minute at 25 C, pH
8.1. Bovine chymotrypsin (EC 3.4.21.1) activity is based on N-
benzoyl-L-tyrosine ethyl ester (BTEE): one unit hydrolyses 1.0
mmol of BTEE per minute at pH 7.8 at 25 C. Porcine pancreatic
lipase (EC 3.1.1.3) activity is based on tributyrin as a substrate:
one unit liberates 1 mmol butyric acid per minute at 37 C and at
pH 8.0. Bile salt concentrations are measured using a
commercial kit (e.g. bile acid kit, ref. 1 2212 99 90 313, DiaSys
Diagnostic System GmbH, Germany or similar).K+ 18.8 26, 27 7.8 27, 28 7.6 27, 28
Na+ 13.6 27 72.2 27–29 123.4 27, 28
Cl 19.5 26, 27 70.2 27, 28 55.5 27
H2PO4
 3.7 30 0.9 27 0.8 27
HCO3
, CO3
2 13.7 27 25.5 27 85 27
Mg2+ 0.15 26, 27 0.1 27 0.33 27
NH4
+ 0.12 27 1.0 27 —
Ca2+ 1.5 26, 27 0.15 27, 28 0.6 27, 28Simulated digestion uids
Simulated Salivary Fluid (SSF), Simulated Gastric Fluid (SGF)
and Simulated Intestinal Fluid (SIF) are made up of the corre-
sponding electrolyte stock solutions (Tables 1 and 2), enzymes,
CaCl2 and water. The electrolyte stock solutions are 1.25
concentrated i.e. 4 parts of electrolyte stock solution + 1 part
water give the correct ionic composition in the simulatedThis journal is © The Royal Society of Chemistry 2014digestion uids. For example 3.8 mL SGF electrolyte stock
solution + 0.2 mL pepsin (made up in SGF electrolyte stock
solution) + 25 mL 0.3 M CaCl2 + 975 mL water ¼ 5 mL SGF.
Enzyme activities are in units per mL of nal digestion mixture
rather than secretion activity, unless stated otherwise.
Oral phase
Mastication of solid food is simulated by mincing an appro-
priate amount of food using a commercially available manual or
electric mincer, such as the Eddingtons Mincer Pro (Product
Code 86002, Berkshire, UK) or similar, commonly used in
kitchens to mince meat. SSF electrolyte stock solution is added
to create a thin paste-like consistency, similar to that of tomato
paste or mustard. If necessary, the electrolyte stock solution can
also be added during mincing. A nal ratio of food to SSF of
50 : 50 (w/v) is targeted. For liquid food an oral phase can be
included, especially if the meal contains starch. In this case a
nal ratio of 50 : 50 (v/v) is targeted. Human salivary a-amylase
(EC 3.2.1.1) is added to achieve 75 U mL1 in the nal mixture,
followed by CaCl2 to achieve 0.75 mM in the nal mixture and
the necessary amount of water to dilute the stock solution of
SSF. The recommended time of contact with the enzyme is 2
minutes at 37 C, which requires pre-warming of all reagents to
37 C.
In a typical example: 5 g of solid or 5 mL of liquid food is
mixed with 3.5 mL of SSF electrolyte stock solution and minced
together. 0.5 mL salivary a-amylase solution of 1500 U mL1
made up in SSF electrolyte stock solution (a-amylase from
human saliva Type IX-A, 1000–3000 U mg1 protein, Sigma) is
added followed by 25 mL of 0.3 M CaCl2 and 975 mL of water and
thoroughly mixed.
Gastric phase
Liquid food can be exposed to the oral phase (optional) or
directly to gastric phase, as further discussed in the main
section of the manuscript. Five parts of liquid food or oral
bolus, is mixed with 4 parts of SGF stock electrolyte solution to
obtain a nal ratio of food to SGF of 50 : 50 (v/v) aer addition of
other recipients and water. Porcine pepsin (EC 3.4.23.1) is
added to achieve 2000 U mL1 in the nal digestion mixture,Food Funct., 2014, 5, 1113–1124 | 1115
Table 2 Preparation of stock solutions of simulated digestion fluids. The volumes are calculated for a final volume of 500mL for each simulated
fluid. We recommend to make up the stock solution with distilled water to 400 mL instead, i.e. 1.25 concentrate, for storage at 20 C. In the
Experimental section, these 1.25 concentrates are referred to as Simulated Salivary Fluid (SSF), Simulated Gastric Fluid (SGF) and Simulated
Intestinal Fluid (SIF) electrolyte stock solutions. The addition of enzymes, bile salts, Ca2+ solution etc. and water will result in the correct
electrolyte concentration in the final digestion mixture. CaCl2(H2O)2 is not added to the electrolyte stock solutions as precipitation may occur.
Instead, it is added to the final mixture of simulated digestion fluid and fooda
Constituent Stock conc.
SSF SGF SIF
pH 7 pH 3 pH 7
Vol. of stock Conc. in SSF Vol. of stock Conc. in SGF Vol. of stock Conc. in SIF
g L1 mol L1 mL mmol L1 mL mmol L1 mL mmol L1
KCl 37.3 0.5 15.1 15.1 6.9 6.9 6.8 6.8
KH2PO4 68 0.5 3.7 3.7 0.9 0.9 0.8 0.8
NaHCO3 84 1 6.8 13.6 12.5 25 42.5 85
NaCl 117 2 — — 11.8 47.2 9.6 38.4
MgCl2(H2O)6 30.5 0.15 0.5 0.15 0.4 0.1 1.1 0.33
(NH4)2CO3 48 0.5 0.06 0.06 0.5 0.5 — —
For pH adjustment
mol L1 mL mmol L1 mL mmol L1 mL mmol L1
NaOH 1 — — — — — —
HCl 6 0.09 1.1 1.3 15.6 0.7 8.4
CaCl2(H2O)2 is not added to the simulated digestion uids, see details in legend
g L1 mol L1 mmol L1 mmol L1 mmol L1
CaCl2(H2O)2 44.1 0.3 1.5 (0.75*) 0.15 (0.075*) 0.6 (0.3*)
a * in brackets is the corresponding Ca2+ concentration in the nal digestion mixture.
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View Article Onlinefollowed by CaCl2 to achieve 0.075 mM in the nal digestion
mixture. 1 M HCl is added to reduce the pH to 3.0; it is rec-
ommended to determine the amount of required acid in a test
experiment prior to digestion, hence acid can be added more
rapidly and followed by verication of the pH. Finally, the
necessary amount of water is added to the mixture to dilute the
stock solution of SGF. The use of gastric lipase is not recom-
mended at this time because it is not commercially available
(further discussed in the main text). The recommended time of
digestion is 2 hours at 37 C. The pHmay have to be re-adjusted
with 1 M HCl during digestion. Sufficient mixing during
digestion is recommended, for example by placing the reaction
vessel into a shaking incubator, water bath with integrated
shaker or a rotator in a 37 C room.
In a typical example: 10 mL of liquid sample or oral bolus is
mixed with 7.5 mL of SGF electrolyte stock solution, 1.6 mL
porcine pepsin stock solution of 25 000 UmL1 made up in SGF
electrolyte stock solution (pepsin from porcine gastric mucosa
3200–4500 U mg1 protein, Sigma), 5 mL of 0.3 M CaCl2, 0.2 mL
of 1 M HCl to reach pH 3.0 and 0.695 mL of water.Non-standard gastric condition
In the absence of phospholipids or other low molecular weight
surfactants in the tested food, it is recommended to include
phospholipids (0.17 mM in the nal digestion mixture) in the
gastric step. In this case freshly prepared SGF containing
phospholipids is used instead of SGF. All other steps are as
outlined above. For non-standard gastric condition using1116 | Food Funct., 2014, 5, 1113–1124phospholipids, the following procedure is recommended.
Prepare a stock solution of 50 mg mL1 egg lecithin (Lipid
Products, Redhill UK, 500 mg egg lecithin, approx. 63.5 mM,
assuming mean Mw: 787 g mol
1) by adding 1 vial containing
500 mL egg lecithin into a 10 mL volumetric ask wrapped in
aluminium foil and lling with chloroform–methanol (1 : 1)
solution up to the 10 mL mark; mix until dissolved. This can be
stored for a several days at 20 C until required. Gastric lipo-
somes (phospholipids) are prepared the day of usage: a 1 mL
aliquot of the 50 mg mL1 phospholipid stock solution is dried
using a rotary evaporator until solvent is removed or dry
remaining solvent under inert gas if no rotary evaporator is
available, leaving 50 mg of dry phospholipids. Add 5 mL warm
SGF to reach nal concentration of 10 mg mL1 phospholipids
in SGF. Incubate at 37 C, shaking at 170 rpm, for 10 min.
Sonicate the solution in an ice bath until clear to the eye. Filter
the sample through a 0.22 mm nylon syringe lter (Thermo
Scientic™ Nalgene Syringe Filters or similar products) to
remove any debris deposited by sonicator. The solution should
be stored at 4 C and used the same day.Intestinal phase
Five parts of gastric chyme is mixed with 4 parts of SIF elec-
trolyte stock solution to obtain a nal ratio of gastric chyme to
SIF of 50 : 50 (v/v) aer additions of other recipients and water.
The gastric samples–chyme is mixed with SIF electrolyte stock
electrolyte solution. Addition of base (1 M NaOH) will be
required to neutralise the mixture to pH 7.0. Digestive enzymesThis journal is © The Royal Society of Chemistry 2014
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View Article Onlinecan be added as either pancreatin from porcine pancreas or
individual enzymes. In the case of pancreatin, proteolytic,
lipolytic and amylolytic activity of the extract should be deter-
mined using the assays outlined in Enzyme assays section. The
amount of pancreatin added is based on the trypsin activity (100
U mL1 in the nal mixture). If the food contains high amounts
of fat or the fat digestion is at the centre of the study, pancreatin
concentration should be either based on the lipase activity or
additional porcine pancreatic lipase and colipase should be
added to achieve 2000 U mL1 lipase activity in the nal
mixture. This is further discussed in the main section of the
paper. Alternatively, individual enzymes can be added to the
digestion mixture to achieve the following activities in the nal
mixture: porcine trypsin (EC 3.4.21.4) (100 U mL1), bovine
chymotrypsin (EC 3.4.21.1) (25 U mL1), porcine pancreatic a-
amylase (EC 3.2.1.1) (200 UmL1), porcine pancreatic lipase (EC
3.1.1.3) (2000 U mL1) and porcine pancreatic colipase (2 : 1
colipase to lipase molar excess, equivalent to a mass ratio of
roughly 1 : 2 co-lipase to lipase as the mass of human pancre-
atic lipase is 51.2 kDa and the mass of human co-lipase is 10
kDa). Bile salts are added to give a nal concentration of 10 mM
in the nal mixture. There are two options for bile; in both cases
the concentration of bile salts needs to be determined, (see
assay in Enzyme assays section): bile extract such as B8631
(porcine) or B3883 (bovine) from Sigma-Aldrich or fresh (frozen)
porcine bile. CaCl2 is added to reach 0.3 mM in the nal
digestion mixture. It is recommended to assay the Ca2+ content
in pancreatin, if used, and take this into account when adding
Ca2+ to the digestive mixture. The pH may need re-adjustment
before nally adding water to the mixture to dilute the stock
solution of SIF. The recommended time of intestinal digestion
is 2 hours at 37 C. The pH may need re-adjustment during
digestion. This can be achieved either manually or by auto-
mated laboratory titrator.
In a typical example, 20 mL of gastric chyme is mixed with 11
mL of SIF electrolyte stock solution, 5.0 mL of a pancreatin
solution 800 U mL1 made up in SIF electrolyte stock solution
based on trypsin activity (pancreatin from porcine pancreas,
Sigma), 2.5 mL fresh bile (160 mM in fresh bile), 40 mL of 0.3 M
CaCl2, 0.15 mL of 1 M NaOH to reach pH 7.0 and 1.31 mL of
water. It is recommended to verify the pH and determine the
amount of NaOH–HCl required in a test experiment prior
digestion, hence base–acid can be added more rapidly and
followed by verication of the pH.Sampling during digestion
Sample conservation depends on the study focus (food struc-
ture, bioaccessibility, enzymatic digestion product etc.), and
should be carefully considered for each study. It may be advis-
able to have individual sample tubes for each time point rather
than withdrawing samples from the reaction vessel. Here are
some recommendations to inhibit or slow down further enzy-
matic action on the food sample:
(i) Snap freezing of samples is recommended in liquid
nitrogen immediately aer the reaction for further analysis. (ii)
If samples are sent to other labs, i.e. by courier or by post, theThis journal is © The Royal Society of Chemistry 2014digestion has to be stopped completely; the following proce-
dures are recommended: (a) neutralization of pH in the gastric
phase by adding 0.5M sodium bicarbonate before snap-freezing
in liquid nitrogen and subsequent freeze drying of the samples
or (b) addition of protease inhibitor (e.g. 1 mM 4-(2-aminoethyl)
benzenesulfonyl uoride hydrochloride [AEBSF], Roche or
similar), snap freezing in liquid nitrogen and subsequent freeze
drying of samples.In vitro digestion parameters –
recommendation and justification
Oral phase
Mastication and duration of oral phase. In the oral cavity the
texture of solid food is signicantly altered by mastication and
salivation. The food is wetted and lubricated by salivary secre-
tion resulting in a cohesive bolus that is ready for swallowing.
Mastication is a complex process that is inuenced by a number
of factors like food composition, food volume, number of
chewing cycles, bite force, teeth condition, degree of hunger
and habits.31–34 This all affects size, surface area and shape of
food particles.35 A prediction of particle sizes and particle
numbers resulting frommastication that is based on toughness
and Young's modulus of food particles can be obtained using
the Food Fragmentation Index.35 The particle-size distribution
of the bolus depends largely on food type. Peyron et al.36 and
others compared the boluses produced aer mastication of raw
vegetables (carrot, radish, and cauliower) and nuts (peanut,
almond, and pistachio). Raw vegetables were transformed into
similar boluses made up of particles larger than 2mm, and nuts
gave similar boluses containing 90% of particles smaller than 2
mm. In general, particle sizes of less than 2mm are accepted for
swallowing unless larger food particles are so enough to be
swallowed.36,37 In consideration of the highly individual chew-
ing time and the complex situation of food breakdown during
mastication we recommend standardizing the size of solid food
particles by using a commercial mincer commonly used in
kitchens. Versantvoort et al.6 recommended an oral digestion
time of 5 minutes in order to ensure proper mechanical action
for static models. However, chewing time in vivo is generally
much shorter. Therefore, a simulated oral phase of 2 min, i.e.
the contact time with enzyme, is recommended in this model.
This is somewhat longer than in vivo, however, accuracy and
reproducibility in a lab situation may be compromised if using
any shorter digestion time. In case of liquid food the simulation
of an oral phase may be included, especially if themeal contains
starch. However, most liquids do not require an oral phase,
mainly due to the very short residence times in the oral cavity.
Volume of salivary secretions. Salivary secretion is also of
inuence on parameters of the liquid phase of food like pH
value, surface tension and viscosity. Human saliva is a watery
complex uid, which is mainly produced by the parotid, the
sublingual and the submandibular glands. The total amount of
saliva produced per day is in the range of 1 to 1.5 L.38,39 Saliva is
excreted at different rates in the stimulated and unstimulated
states. The stimulated salivary ow that is contributing to foodFood Funct., 2014, 5, 1113–1124 | 1117
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View Article Onlinedigestion is a hypo-osmotic (110–220mOsmol kg1) uid.40–42 In
addition to 99.5% of water, human saliva contains 0.3% of
proteins as well as various electrolytes like sodium, potassium,
calcium, magnesium, phosphate and bicarbonate. Further
components are glucose and nitrogenous products as urea. The
main proteins are immunoglobulin A (IgA), a-amylase (ptyalin),
lysozyme, lactoferrin, as well as mucosal glycoproteins
(mucins).38 In order to simulate the wetting and lubrication of
solid foodmasses by salivation we recommend that at least 50%
(w/v) of simulated salivary uid (SSF) is added to solid food
masses prior to the homogenization process. The amount of
SSF should be high enough to achieve a paste-like consistency,
similar to that of tomato paste or mustard. The best lubricating
components of saliva are mucins that are excreted from minor
salivary glands. Mucins have the properties of low solubility,
high viscosity, high elasticity, and strong adhesiveness. Masti-
cation, speech, and swallowing all are aided by the lubricating
effects of mucins.43 Versantvoort et al.6 and Sarkar et al.44 both
referred the use of 0.005 and 3% (w/v) mucin, respectively. The
main objective of the simulation is to help the formation of the
bolus that is largely held together by capillary force and allow a
solution for the addition of amylase; mucin is not required for
either of these. Besides, mucin is only a minor component of
saliva thus it was not used in this standardized digestion
method.
Amylase activity and pH. Salivary a-amylase (ptyalin) has a
pH optimum at pH 6.8.42 Its activity is generally limited to the
mouth cavity and early gastric digestion when the pH can be
high enough due to the buffering capacity of food. a-Amylase is
inactivated by the acid milieu and the proteolytic activity in the
stomach. It is therefore oen regarded to be of lesser signi-
cance compared to the pancreatic a-amylase.45 However, it has
also been reported that even during 20 to 30 s of oral food
processing, 50% of the starch in bread and 25% of the starch in
spaghetti can already be hydrolysed.46 Recent studies have
shown that a-amylase plays an important role in the in vitro
breakdown kinetics of bread boluses,47 and between 25 and
50% of the starch in bread and pasta boluses was hydrolysed by
salivary a-amylase in vivo.46 While a small portion of starch is
hydrolysed by the enzyme a-amylase due to the short retention
time, almost no protein or fat digestion occurs in the mouth.
Therefore we recommend a 2 min incubation, which may
include mastication at the same time, see above, with a nal
concentration of 75 U mL1 of a-amylase in the mixture of food
and SSF in case of the presence of carbohydrates that are
digestible by a-amylase. Aer oral processing solid food is
emptied from the oral cavity typically in at least two swallows for
each bite.48 Oesophageal passage is a short process with transit
times of a few seconds.49 No effect on food digestion has been
reported.Gastric phase
The primary purpose of the stomach is to deliver digesta to the
duodenum in a regulated manner to optimize intestinal diges-
tion. In the lower part of the stomach (antrum), the meal is
mixed and digested with secreted enzymes and hydrochloric1118 | Food Funct., 2014, 5, 1113–1124acid, ground by antral movements, and gradually emptied into
the duodenum. The signicance of physiological and simulated
gastric parameters will be discussed.
Duration of gastric step. Gastric emptying of a western type
solid meal is usually completed between 3 and 4 h.50–52 An initial
lag phase may be observed before the linear decrease in gastric
content.53,54 Homogenization of the solid meal usually leads to a
one-hour reduction of the length of gastric digestion.55 By
contrast, liquid meal digestion is characterized by an expo-
nential emptying course with rapid onset of emptying.
Emptying of 300 mL of water requires 1 h (ref. 56) whereas other
studies on liquids with a low protein concentration has shown
even shorter transit time (0.5 h).56 The addition of nutrients
(proteins, lipids or carbohydrates) to a liquid meal also affects
the transit time.57,58 In addition, the inter- and even intra-indi-
vidual day to day variations in gastric secretion affects pH and
the rate of gastric emptying.59 A simplied static model cannot
reproduce the dynamic and transient nature of the in vivo
digestion process and the food is exposed to gastric conditions
reached at approximately half-gastric emptying time. The pH is
relatively low from the start of the digestion process, without the
initial buffering effect of the food. Similarly, the food is exposed
to an enzyme–substrate ratio, which is normally only reached at
half-gastric emptying time. The conditions of the digestion
protocol we recommend need to be applicable to a broad range
of meals, therefore we recommend a time of two hours for
gastric digestion. This time represents the half emptying of a
moderately nutritious and semi-solid meal.
Volume of gastric secretions. The total volume of gastric
secretion depends on fasted and fed state of humans and the
consistency of the meal. A liquid meal will usually require from
half to one volume of gastric secretion for digestion.60,61 By
contrast, two volumes of gastric juices are secreted for a solid
meal.53,60 The secretion during the rst hour represents half of
the total secreted volume for both the liquid and solid meals,
even though a continuous emptying will occur that is not
possible to simulate by in vitro static digestion. It is thus advised
to use one volume of simulated gastric juice for one volume of
oral content whatever the meal physical state.
pH. Aer food intake, pH usually increases to 5 and above
because of the buffering capacity of a typical western-type
diet,51,62 enriched in vegetable purees52 or a cocoa beverage.63
The secretion of hydrochloric acid lowers the pH to the values
required for optimal enzyme activities. Consequently, pH slowly
returns to fasted pH which is commonly found below 2.64
Slightly acidic conditions with pH ranging from 4 to 6 are
required for optimal gastric lipase activity64 while pepsin will be
mainly active between pH 2 and 4. In order to match the 2 hour
recommendation for the length of the gastric simulation the pH
we recommend must represent a mean value for a general meal
as described above over the two hours suggested. Thus we
recommend the use of a static value of pH 3.
Pepsin activity. Pepsin is the only proteolytic enzyme in the
human stomach, however, many isoforms exist. The pepsin
content in the stomach varies with individuals, however, mainly
increases upon digestion from 0.26 (30 min) to 0.58 mg mL1
(180 min).62 Large variations in pepsin activities are reported inThis journal is © The Royal Society of Chemistry 2014
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View Article Onlinethe literature, partly due to the use of different assays and
calculations.65–67 Our aim is to produce a standardised proce-
dure and for this purpose pepsin activity is assayed using hae-
moglobin (Hb) as a substrate, see ESI,† where one unit will
produce a DA280 of 0.001 per minute at pH 2.0 and 37 C,
measured as TCA-soluble products, also referred to as “Sigma”
or “Anson” pepsin units.68,69 A high homology between human
and porcine pepsins (84%) and the low cost of porcine pepsin
from gastric mucosa support a regular use of porcine pepsin in
static in vitro digestion models.70 Based on an evaluation of
values given in the literature65–67 we suggest that porcine pepsin
is used at 2000 U mL1 nal digestion mixture (equivalent to
4000 U mL1 in secretion).
Gastric lipase activity. Lipase activity is markedly lower in the
gastric compartment (10–120 U mL1) compared to that in the
duodenal tract (80–7000 U mL1).71,72 Gastric lipolysis is only
partial (5–40%) mainly because of the lower amounts of enzyme
present and its pH activity prole.71 In the absence of tri-
acylglycerols or when the digestion of proteins and poly-
saccharides is the main focus of the study, the addition of lipase
in the gastric step of digestion can be omitted. Human gastric
lipase or alternatives with similar characteristics are commer-
cially unavailable at this time and alternatives such as fungal
lipases73,74 exhibit different activities and specicities.75 For
these reasons, gastric lipase is not included in the protocol at
this time.
Bile salts. Low concentrations of bile acids (0.2 mM) may be
found in the human fasting gastric uid28 although not in all
individuals. The detection of a concomitant pancreatic lipase
activity suggested possible duodeno-gastric reux.76 Thus, bile
acids in the gastric phase will not be further considered in this
protocol.
Phospholipids. Low concentrations of phospholipids are
found in the gastric compartment77 and these have been shown
to affect the rate of protein digestion in the gastric and small
intestinal environments.78,79 The presence of surface active
components such as phospholipids also has a marked effect on
the extent of re-emulsication of lipids as it passes through the
high shear regions of the pylorus. Therefore in the absence of
phospholipids or other low molecular weight surfactants
present in the food, 0.17 mM phospholipids in the nal gastric
solution is recommended to be included in this static model as
optional, non-standard gastric conditions.Small intestine
Once the food has been through the simulated gastric phase of
digestion it is transferred to a simulation of the digestion that
occurs in the small intestine. It is reasonable to assume that this
part of the simulation should be well mixed. Once again we
suggest that the gastric contents should be diluted 50 : 50 v/v
with simulated intestinal uid (SIF) as given in Table 2. There
are many variables that have an impact on transit time through
the small intestine but we suggest the time of simulated intes-
tinal digestion should be 2 hours.6,7,80 Aer emptying from the
gastric compartment chyme is normally neutralised by the
secretion of carbonate. Consequently the duodenal pH isThis journal is © The Royal Society of Chemistry 2014around pH 6.5 depending on such factors as meal type and
gastric emptying rate. The pH then increases slightly over its
length to a value of around 7.5 in the distal ileum. Thus, in
order to mimic the pH in the entire passage through the small
intestinal phase in static conditions, we recommend using an
average value of 7.06,7,62 through the addition of SIF and sodium
hydroxide.
The most important components of the simulated small
intestinal digestion are the pancreatic enzymes and the bile. In
both cases we suggest that there are essentially two options
offering differences in specicity, ease of use and cost of each
experiment. For the enzymes we recommend either individual
enzymes or porcine pancreatin and for bile we recommend the
use of either bile extract or frozen porcine bile. There are some
guiding principles that should be considered when deciding
what approach to use. In the case of the bile, if the proposed
experiment involves accurately following lipid hydrolysis in
detail then frozen porcine bile should be used, otherwise the
bile extract should suffice. The same argument could be used
for the use of individual enzymes in that for a detailed analysis
of lipid hydrolysis individual enzymes should be used or indeed
if the system contains only protein, lipid or starch then the use
of only proteases, lipases or amylase respectively may be
appropriate. However, the cost and availability of enzymes
should also be considered. In both cases the selection of the
amount to use in a static model is difficult to assess as physi-
ological measurements refer more to secretion rates rather than
specic amounts.
Pancreatin. Porcine pancreatin is readily available and
contains all the important pancreatic enzymes in differing
amounts. However, as our aim is to produce a standardised
procedure we must base the amount added on the activity of a
specic enzyme and for this purpose, trypsin is the most
appropriate. Thus we recommend that either 4 USP (U.S.
Pharmacopeia) or 8 USP pancreatin is used and its trypsin
activity assayed using the p-toluene-sulfonyl-L-arginine methyl
ester (TAME) assay.81 The amount of pancreatin added should
then be based on the trypsin assay and should be sufficient to
provide 100 TAME units per mL of intestinal phase content. The
proteolytic, lipolytic and amylolytic activity of the pancreatin
should also be determined. In addition, pancreatin also
contains signicant amounts of various salts and given the
importance of the Ca2+ concentration in SIF we suggest that this
is also assayed and taken into account when adding calcium to
the SIF. It is important to recognise that the concentration of
lipase and amylase in the pancreatin will differ from those
recommended below and thus for high fat foods this approach
may not be appropriate.
Individual enzymes. The alternative to using pancreatin is
to use individual enzymes but then which enzymes should be
included and how much activity should be used? The primary
proteolytic enzymes in the lumen of the small intestine are
trypsin and chymotrypsin. Based on an evaluation of values
given in the literature we suggest that porcine trypsin is used at
100 U mL1 nal concentration.80 The activity is in TAME units
where one unit hydrolyses 1 mmol of p-toluene-sulfonyl-L-argi-
nine methyl ester (TAME) per minute at 25 C, pH 8.1, in theFood Funct., 2014, 5, 1113–1124 | 1119
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View Article Onlinepresence of 10 mM calcium ions.82 The equivalence between
TAME and BAEE units is: 1 TAME mM unit ¼ 55 BAEE A253
units or 100 TAME U ¼ 5560 BAEE units. Chymotrypsin should
be used at 25 U mL1 nal concentration.83 The chymotrypsin
activity is in N-benzoyl-L-tyrosine ethyl ester (BTEE) units where
one unit will hydrolyse 1.0 mmol of BTEE per minute at pH 7.8
at 25 C.84 The ratio of chymotrypsin to trypsin is based on the
work of Goldberg et al., who showed that the mass ratio of the
two enzymes in human duodenal aspirates averaged about
2 : 1 trypsin to chymotrypsin and this corresponds to a 4 : 1
activity ratio. This is based on the activity of trypsin being 135
TAME U mg1 and the activity of chymotrypsin being 64 BTEE
U mg1. The main carbohydrate hydrolysing agent is pancre-
atic amylase that should be added at 200 U mL1 nal
concentration85 where one unit will liberate 1.0 mg of maltose
from corn starch in 3 min at pH 6.9 at 20 C.86 The most
difficult enzymes to accurately quantify in terms of activity are
the lipases. We recommend using porcine pancreatic lipase at
2000 U mL1 (ref. 87) where 1 unit will release 1 mmol of free
fatty acid per minute from a substrate of tributyrin at 37 C, pH
8.0, in the presence of 2 mM calcium ions and 4 mM sodium
taurodeoxycholate and excess colipase. This amount is based
on the mean detection of 0.25 mg mL1 pancreatic lipase in
duodenal aspirates and the activity of the pure enzyme
being 8000 U mg1. The assay should be conducted
according to the recommendations of Carrie`re and co-
workers,88,89 also available at the CNRS website (http://eipl.cnrs-
mrs.fr/assay.php?module¼voir&id¼1). In the presence of bile,
the rate of lipolysis is signicantly improved by the presence of
co-lipase, which facilitates the binding of the lipase to
the substrate. The co-lipase binds to the lipase in order to
enable the lipase to adsorb to the oil–water interface. Thus, it
is important to ensure that the co-lipase is added in a 2 : 1
molar excess with the lipase. This is equivalent to a mass ratio
of roughly 1 : 2 co-lipase–lipase as the mass of the similar
human pancreatic lipase is 51.2 kDa and the mass of human
co-lipase is 10 kDa. Commercially available pancreatin usually
contains enough colipase for maximum lipase activity, which
can be veried, if necessary, by adding additional colipase in
the course of the lipase assay and record changes in lipase
activity.
Bile. Bile is important for the transport of the products of
lipolysis and in the adult intestine the typical concentration in
the fed state is 10 mM nal concentration in total uid.62 As
discussed above, we suggest two options for sources of bile for
the intestinal stage, which are either to use a porcine or bovine
bile extract90 or frozen porcine bile, which is easily extracted
from the porcine gall bladder. In either case the concentration
of bile salts will need to be determined so that in the SIF the
concentration is made up to 20 mM, resulting in a concen-
tration of 10 mM in the nal digestion mixture. There are a
number of different commercial kits available for the deter-
mination of bile that are mostly based on similar methods91
(e.g. the bile assay kit 1 2212 99 90 313 from Diagnostic
Systems GmbH in Germany) that can give a bile concentration
in mM.1120 | Food Funct., 2014, 5, 1113–1124Suitability of static digestion models
In vitro digestion studies are widely used with the aim of pre-
dicting the behaviour of food components in the digestive tract.
Most of these studies are performed in static models where
gastric and small intestinal digestion is mimicked in two
consecutive steps. During each step, the substrate is incubated
for a specic time with simulated gastric and small intestinal
digestive uids, respectively. The pH is generally maintained at
a xed value by using a pH-stat or a buffer. This approach allows
methods that are relatively simple to perform and permit high
throughput testing. However, the simplicity of static models
narrows the range of applicability, which drives the need for
adapting a previously described method for a specic research
question. This, and the lack of consensus on relevant physio-
logical conditions, has led to a proliferation of different
methods. In our consortium we aim to harmonize in vitro
systems that simulate digestive processes by dening key
parameters and conditions that need to be included to study a
specic food or substrate and tomeasure a specic endpoint. As
a starting point, we present in this paper a protocol with a set of
standard conditions to be used in a simple static model. These
standard conditions are based on relevant in vivo data and
supported by rationale and source of data. This discussion
focuses on the use and limitation of such a simple static model
in relation to mimicking in vivo conditions.Static models in relation to in vivo conditions
General aspects. The digestive tract is a complex system that
aims to provide the body with optimal nutrition and energy.
Therefore, feedback systems regulate every step of digestion.
The feedback response may differ individually e.g. based on age,
physical constitution (status of the body) and habits. This
results in both food and individual dependent variation of
aspects such as chewing, gastric emptying, secretion of diges-
tive uids and gastro-intestinal transit times. An in vitro diges-
tive system does not include the complex interaction between
food and body, which is oen regarded as the major drawback
of in vitro simulations. Whether or not this really is a drawback
depends on the research question. Control over individual
parameter in mechanistic studies for product optimization
allows the effects of variation in product composition to be
studied under the same conditions. In addition, accurately
controlled conditions do not give the high variability oen
encountered with in vivo studies, thus limiting the need for
large numbers of replicates to obtain sufficient statistical
power.
Oral step. Chewing and the consequent particle size reduc-
tion is a major determinant of the digestion of solid food.
However, the consistency of chewed food, both in terms of
particle size and hydration–lubrication with saliva varies widely
depending on the type of food and the individual. The use of a
food mincer standardizes the particle size and homogeneity of
the food bolus but does not include the interaction between
food and chewing on the digestion. Static models are not able to
mix highly viscous food-saliva boluses as might be swallowed inThis journal is © The Royal Society of Chemistry 2014
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View Article Onlinevivo. Thus, the food needs to be mixed with articial saliva to
obtain a sufficient liquid input for mixing in the gastric step.
Gastric step. The function of the stomach is to prepare and
gradually deliver the meal to the small intestine in order to
optimize further digestion in the small intestine. The meal is
stored in the upper part of the stomach and gradually trans-
ferred to the lower part where the chyme is mixed and ground
until particles are small enough to pass the pylorus. Homoge-
neity of the gastric content in vivo is generally low. The low level
of motility in the upper part of the stomach causes solid
ingested boluses to stack on top of each other and more liquid
gastric content to phase separate.92–94 Gastric emptying occurs
gradually, strongly determined by the caloric value of the
nutrients that enter the duodenum.95 During the gastric phase,
the meal is diluted by gastric juice containing enzymes and
hydrochloric acid. Pepsin, gastric lipase and swallowed salivary
amylase, have their optimum pH at 2.5, 5.4 and 6.8, respec-
tively.42,96,97 In the fasting state, the pH in the stomach is around
2 or below. During ingestion of the meal, the pH increases
depending on the buffer capacity of the meal. Aer that, the pH
is gradually decreasing due to hydrochloric acid secretion. The
slow penetration of acid in a solid food bolus results in a pro-
longed high pH in the interior of the bolus. This all implies that
during gastric emptying different fractions of the meal are
exposed to different pH values and enzyme activities.
Static models use a relatively dilute digestive mixture that is
well homogenised using a stirrer, shaker or impeller. Although
this does not reect the mixing of gastric content in vivo, it
exposes all substrates to the set point pH and related enzyme
activities, and allows representative samples to be taken.
The complete meal with simulated gastric digestive uid is
exposed to a xed pH during a xed period. Generally the gastric
pH is maintained around 2, which may be the right value for the
fasting state but does not reect the pH aer intake of a meal.
Whether or not a static gastric digestion is adequate depends on
the effect of each physiological parameter on the digestion and
intended endpoint. In some cases a gastric step could even be
omitted since the gastric digestion is completely overruled by
the small intestinal digestion. On the other hand, the omission
of gastric lipase during the gastric step, as chosen here, might
not be fully adequate for mimicking the complete process of
gastrointestinal lipolysis as for example preliminary digestion
of dietary triglycerides by gastric lipase is known to further
trigger pancreatic lipase activity on lecithin-stabilized emul-
sions in vitro.98 In other cases incubation at pH 2 during 1 hour
might lead to a complete peptic digestion, while this is not the
case during a much milder exposure in vivo.
Small intestinal step. In the duodenum, the chyme that is
gradually emptied from the stomach is neutralized with bicar-
bonate and mixed with bile and pancreatic juice. Bile is
primarily important to emulsify fat and to form mixed micelles
that solubilise and transport lipophilic products to the gut wall
for absorption. During transit of approximately 3 hours through
the small intestine, substrates and enzyme to substrate ratios
are changing due to the digestion and absorption of digestive
products and water. The major drawback of small intestinal
static models is that they do not include removal of digestiveThis journal is © The Royal Society of Chemistry 2014products during the digestion process, which may cause
product inhibition of enzymes. This is generally overcome by
using non physiological low substrate concentrations in a dilute
system.Use and validation of static models
As with all models, digestive models are a simplication of
reality and should be as simple as possible. However, as Albert
Einstein stated, “we should make things as simple as possible,
but not simpler”. This also applies to designing model systems
to study the behaviour of compounds in the gastro-intestinal
tract. A digestion model should include all relevant parameters
to predict the endpoint intended. The more relevant the
parameters included are, the wider the applicability but also the
higher the complexity.
An accurate prediction of the in vivo bio-accessibility (avail-
ability for absorption through the gut wall) is limited since
static models lack the simulation of realistic enzyme substrate
ratios, pH proles, transit times and removal of digested
products, in time and place. Ranking of the digestion of
different products is more feasible, provided that the set
conditions are adequate for the variation in characteristics of
the products. Static models might also be appropriate for
mechanistic studies, where the digestion of a substrate under
specic conditions is aimed for. The matrix composition of the
different products should not differ too much and should be
limited in complexity. In other words, static models are useful
to study the digestion of single substrates or simple meals
under specic conditions.
In addition to the limitations caused by the applied condi-
tions, the assessment of digestion is strongly affected by the
analysis of the digested fraction. The fraction of product
released should be adequately separated from the undigested
fraction. A centrifugation step will only separate insoluble
undigested material with sufficient density. Undigested
compounds might also be colloidal dispersions. Therefore,
ultra-ltration or dialysis may be the better choice. Analysing
free glucose, amino acids or fatty acids to determine the
digestibility of macro-nutrients is not appropriate, since the
pancreatic digestion is not complete. Therefore an additional
step with brush border enzymes such as amylo-glucosidase or
peptidase is required to complete starch and protein digestion,
respectively. Analysis of lipid digestion in a static model is
generally performed in a pH stat where the produced fatty acids
are assumed to be equivalent to the amount of neutralizing
alkali. Product inhibition can be overcome by continuous
addition of Ca2+ ions to precipitate free fatty acids as calcium
soaps.99
In contrast to the more holistic dynamic models that should
be validated for their ability to reproduce the conditions in the
gut, a static model should be validated against their intended
use. In this paper we have described a protocol with conditions
and composition of digestive uids that have a broad consensus
in terms of physiological relevance. This protocol will be tested
and validated by different research groups for a variety of
applications to determine its use and limitations. This processFood Funct., 2014, 5, 1113–1124 | 1121
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View Article Onlinewill lead to the establishment of key parameters and settings for
specic applications and endpoints. This allows model systems
to be adapted and validated for specic applications and
endpoints by choosing the physiological relevant parameters
that have consensus in a big scientic community. This might
lead to also using more complex systems but we should “make
things as simple as possible, but not simpler”.
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